Literature DB >> 26446468

Particle Engineering of Excipients for Direct Compression: Understanding the Role of Material Properties.

Sharad Mangal, Felix Meiser, David Morton, Ian Larson1.   

Abstract

Tablets represent the preferred and most commonly dispensed pharmaceutical dosage form for administering active pharmaceutical ingredients (APIs). Minimizing the cost of goods and improving manufacturing output efficiency has motivated companies to use direct compression as a preferred method of tablet manufacturing. Excipients dictate the success of direct compression, notably by optimizing powder formulation compactability and flow, thus there has been a surge in creating excipients specifically designed to meet these needs for direct compression. Greater scientific understanding of tablet manufacturing coupled with effective application of the principles of material science and particle engineering has resulted in a number of improved direct compression excipients. Despite this, significant practical disadvantages of direct compression remain relative to granulation, and this is partly due to the limitations of direct compression excipients. For instance, in formulating high-dose APIs, a much higher level of excipient is required relative to wet or dry granulation and so tablets are much bigger. Creating excipients to enable direct compression of high-dose APIs requires the knowledge of the relationship between fundamental material properties and excipient functionalities. In this paper, we review the current understanding of the relationship between fundamental material properties and excipient functionality for direct compression.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26446468     DOI: 10.2174/1381612821666151008125117

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  5 in total

1.  Understanding the Performance of a Novel Direct Compression Excipient Comprising Roller Compacted Chitin.

Authors:  Deeb Abu Fara; Linda Al-Hmoud; Iyad Rashid; Babur Z Chowdhry; Adnan Badwan
Journal:  Mar Drugs       Date:  2020-02-17       Impact factor: 5.118

2.  A Direct Compression Matrix Made from Xanthan Gum and Low Molecular Weight Chitosan Designed to Improve Compressibility in Controlled Release Tablets.

Authors:  Deeb Abu Fara; Suha M Dadou; Iyad Rashid; Riman Al-Obeidi; Milan D Antonijevic; Babur Z Chowdhry; Adnan Badwan
Journal:  Pharmaceutics       Date:  2019-11-12       Impact factor: 6.321

3.  Study of Orally Disintegrating Tablets Using Erythritol as an Excipient Produced by Moisture-Activated Dry Granulation (MADG).

Authors:  Mizuki Yamada; Agata Ishikawa; Shun Muramatsu; Takayuki Furuishi; Yoshinori Onuki; Kaori Fukuzawa; Etsuo Yonemochi
Journal:  Pharmaceuticals (Basel)       Date:  2022-08-15

4.  Development of an Age-Appropriate Mini Orally Disintegrating Carvedilol Tablet with Paediatric Biopharmaceutical Considerations.

Authors:  Dilawar Khan; Daniel Kirby; Simon Bryson; Maryam Shah; Afzal Rahman Mohammed
Journal:  Pharmaceutics       Date:  2021-06-03       Impact factor: 6.321

5.  Development of a Solid Formulation Containing a Microemulsion of a Novel Artemisia Extract with Nematocidal Activity for Oral Administration.

Authors:  Ines Perez-Roman; Filip Kiekens; Damian Cordoba-Diaz; Juan Jose Garcia-Rodriguez; Manuel Cordoba-Diaz
Journal:  Pharmaceutics       Date:  2020-09-14       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.